Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Evaluation of human breastmilk adulteration by combining Fourier transform infrared spectroscopy and partial least square modeling.

De Luca M, Ioele G, Spatari C, Caruso L, Galasso MP, Ragno G.

Food Sci Nutr. 2019 May 23;7(6):2194-2201. doi: 10.1002/fsn3.1067. eCollection 2019 Jun.

2.

A successful lung transplant from a 3-year-old donor after controlled cardiac death followed by ex vivo lung perfusion: A case report.

Galasso M, Vanderlaan RD, Solomon M, Caldarone C, Keshavjee S, Cypel M, de Perrot M.

J Thorac Cardiovasc Surg. 2019 Apr 23. pii: S0022-5223(19)30877-3. doi: 10.1016/j.jtcvs.2019.02.131. [Epub ahead of print] No abstract available.

PMID:
31126646
3.

MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma.

Maximov VV, Akkawi R, Khawaled S, Salah Z, Jaber L, Barhoum A, Or O, Galasso M, Kurek KC, Yavin E, Aqeilan RI.

Int J Cancer. 2019 Apr 24. doi: 10.1002/ijc.32368. [Epub ahead of print]

PMID:
31018244
4.

Donor prone positioning protects lungs from injury during warm ischemia.

Watanabe Y, Galasso M, Watanabe T, Ali A, Qaqish R, Nakajima D, Taniguchi Y, Pipkin M, Caldarone L, Chen M, Kanou T, Summers C, Ramadan K, Zhang Y, Chan H, Waddell TK, Liu M, Keshavjee S, Del Sorbo L, Cypel M.

Am J Transplant. 2019 Mar 19. doi: 10.1111/ajt.15363. [Epub ahead of print]

PMID:
30887696
5.

Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration.

Buoso E, Ronfani M, Galasso M, Ventura D, Corsini E, Racchi M.

Pharmacol Res. 2019 May;143:17-26. doi: 10.1016/j.phrs.2019.03.008. Epub 2019 Mar 9.

PMID:
30862604
6.

Needle revision outcomes after glaucoma filtering surgery: survival analysis and predictive factors.

Rabiolo A, Marchese A, Bettin P, Monteduro D, Galasso M, Dolci MP, Di Matteo F, Fiori M, Ciampi C, Bandello F.

Eur J Ophthalmol. 2019 Feb 25:1120672119830861. doi: 10.1177/1120672119830861. [Epub ahead of print]

PMID:
30798630
7.

Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion.

Galasso M, Feld JJ, Watanabe Y, Pipkin M, Summers C, Ali A, Qaqish R, Chen M, Ribeiro RVP, Ramadan K, Pires L, Bagnato VS, Kurachi C, Cherepanov V, Moonen G, Gazzalle A, Waddell TK, Liu M, Keshavjee S, Wilson BC, Humar A, Cypel M.

Nat Commun. 2019 Jan 29;10(1):481. doi: 10.1038/s41467-018-08261-z.

8.

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts.

Agnoletto C, Minotti L, Brulle-Soumare L, Pasquali L, Galasso M, Corrà F, Baldassari F, Judde JG, Cairo S, Volinia S.

Biomark Res. 2018 Oct 30;6:31. doi: 10.1186/s40364-018-0145-8. eCollection 2018.

9.

Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.

Russo V, Paciocco A, Affinito A, Roscigno G, Fiore D, Palma F, Galasso M, Volinia S, Fiorelli A, Esposito CL, Nuzzo S, Inghirami G, de Franciscis V, Condorelli G.

Mol Ther Nucleic Acids. 2018 Dec 7;13:334-346. doi: 10.1016/j.omtn.2018.09.016. Epub 2018 Sep 27.

10.

The Effect of Heart Rate on Jump-Shot Accuracy of Adolescent Basketball Players.

Padulo J, Nikolaidis PT, Cular D, Dello Iacono A, Vando S, Galasso M, Lo Storto D, Ardigò LP.

Front Physiol. 2018 Aug 3;9:1065. doi: 10.3389/fphys.2018.01065. eCollection 2018.

11.

Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.

Baldassari F, Zerbinati C, Galasso M, Corrà F, Minotti L, Agnoletto C, Previati M, Croce CM, Volinia S.

Front Genet. 2018 May 18;9:174. doi: 10.3389/fgene.2018.00174. eCollection 2018.

12.

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.

Volinia S, Bertagnolo V, Grassilli S, Brugnoli F, Manfrini M, Galasso M, Scatena C, Mazzanti CM, Lessi F, Naccarato G, Caligo A, Bianchini E, Piubello Q, Orvieto E, Rugge M, Natali C, Reale D, Vecchione A, Warner S, Croce CM, Capitani S.

Oncotarget. 2018 May 4;9(34):23543-23553. doi: 10.18632/oncotarget.25261. eCollection 2018 May 4.

13.

Loss of miR-204 expression is a key event in melanoma.

Galasso M, Morrison C, Minotti L, Corrà F, Zerbinati C, Agnoletto C, Baldassari F, Fassan M, Bartolazzi A, Vecchione A, Nuovo GJ, Di Leva G, D'Atri S, Alvino E, Previati M, Nickoloff BJ, Croce CM, Volinia S.

Mol Cancer. 2018 Mar 9;17(1):71. doi: 10.1186/s12943-018-0819-8.

14.

An Ultraconserved Element Containing lncRNA Preserves Transcriptional Dynamics and Maintains ESC Self-Renewal.

Fiorenzano A, Pascale E, Gagliardi M, Terreri S, Papa M, Andolfi G, Galasso M, Tagliazucchi GM, Taccioli C, Patriarca EJ, Cimmino A, Matarazzo MR, Minchiotti G, Fico A.

Stem Cell Reports. 2018 Mar 13;10(3):1102-1114. doi: 10.1016/j.stemcr.2018.01.014. Epub 2018 Feb 15.

15.

A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants.

Minotti L, Baldassari F, Galasso M, Volinia S, Bergamini CM, Bianchi N.

Amino Acids. 2018 Apr;50(3-4):421-438. doi: 10.1007/s00726-017-2528-9. Epub 2018 Jan 8.

PMID:
29313085
16.

Role of Hormones in the Regulation of RACK1 Expression as a Signaling Checkpoint in Immunosenescence.

Racchi M, Buoso E, Ronfani M, Serafini MM, Galasso M, Lanni C, Corsini E.

Int J Mol Sci. 2017 Jul 6;18(7). pii: E1453. doi: 10.3390/ijms18071453. Review.

17.

Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients.

Fatigato G, Capitani S, Milani D, Grassilli S, Alameen AA, Candiani M, Riberti C, Galasso M, Previati M.

Eur J Dermatol. 2017 Aug 1;27(4):363-368. doi: 10.1684/ejd.2017.3026.

PMID:
28524055
18.

miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.

Cappellesso R, Galasso M, Nicolè L, Dabrilli P, Volinia S, Fassina A.

Cancer Cytopathol. 2017 Aug;125(8):635-643. doi: 10.1002/cncy.21869. Epub 2017 Apr 27.

19.

The scaffold protein RACK1 is a target of endocrine disrupting chemicals (EDCs) with important implication in immunity.

Buoso E, Galasso M, Ronfani M, Papale A, Galbiati V, Eberini I, Marinovich M, Racchi M, Corsini E.

Toxicol Appl Pharmacol. 2017 Jun 15;325:37-47. doi: 10.1016/j.taap.2017.04.011. Epub 2017 Apr 13.

PMID:
28412309
20.

Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease.

Diani M, Galasso M, Cozzi C, Sgambelluri F, Altomare A, Cigni C, Frigerio E, Drago L, Volinia S, Granucci F, Altomare G, Reali E.

Clin Immunol. 2017 Jul;180:84-94. doi: 10.1016/j.clim.2017.04.001. Epub 2017 Apr 6.

PMID:
28392462
21.

Role of spliceosome proteins in the regulation of glucocorticoid receptor isoforms by cortisol and dehydroepiandrosterone.

Buoso E, Galasso M, Ronfani M, Serafini MM, Lanni C, Corsini E, Racchi M.

Pharmacol Res. 2017 Jun;120:180-187. doi: 10.1016/j.phrs.2017.03.019. Epub 2017 Mar 31.

PMID:
28373129
22.

Detection of Pneumocystis jirovecii by nested PCR in HIV-negative patients with pulmonary disease.

Santos CR, de Assis ÂM, Luz EA, Lyra L, Toro IF, Seabra JCC, Daldin DH, Marcalto TU, Galasso MT, Macedo RF, Schreiber AZ, Aoki FH.

Rev Iberoam Micol. 2017 Apr - Jun;34(2):83-88. doi: 10.1016/j.riam.2015.12.002. Epub 2017 Feb 15.

PMID:
28214275
23.

Transcriptional regulation of RACK1 and modulation of its expression: Role of steroid hormones and significance in health and aging.

Buoso E, Galasso M, Serafini MM, Ronfani M, Lanni C, Corsini E, Racchi M.

Cell Signal. 2017 Jul;35:264-271. doi: 10.1016/j.cellsig.2017.02.010. Epub 2017 Feb 9. Review.

PMID:
28192162
24.

Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study.

Galasso M, Costantino G, Pasquali L, Minotti L, Baldassari F, Corrà F, Agnoletto C, Volinia S.

Int J Genomics. 2016;2016:4503840. Epub 2016 Nov 14.

25.

Antiplatelet therapy in patients with glucose-6-phosphate dehydrogenases deficiency after percutaneous coronary intervention: A reappraisal for clinical and interventional cardiologists.

Zuin M, Rigatelli G, Carraro M, Galasso MP, Dell'Avvocata F, Paolini R, Zuliani G, Roncon L.

Cardiovasc Revasc Med. 2017 Apr - May;18(3):226-229. doi: 10.1016/j.carrev.2016.11.011. Epub 2016 Nov 28. Review.

PMID:
27914991
26.

Effects of two diet techniques and delivery mode on weight loss, metabolic profile and food intake of obese adolescents: a fixed diet plan and a calorie-counting diet.

Mendes MD, de Melo ME, Fernandes AE, Fujiwara CT, Pioltine MB, Teixeira A, Coelho K, Galasso M, Cercato C, Mancini MC.

Eur J Clin Nutr. 2017 Apr;71(4):549-551. doi: 10.1038/ejcn.2016.176. Epub 2016 Sep 21.

PMID:
27650876
27.

Cardiovascular disease in patients with inflammatory bowel disease: An issue in no guidelines land.

Zuin M, Rigatelli G, Del Favero G, Andreotti AN, Picariello C, Zuliani G, Carraro M, Galasso MP, Roncon L.

Int J Cardiol. 2016 Nov 1;222:984-985. doi: 10.1016/j.ijcard.2016.08.101. Epub 2016 Aug 5. No abstract available.

PMID:
27526375
28.

A theoretical comparison of position estimation methods for determining the interaction position of gamma rays in monolithic scintillators.

Galasso M, Borrazzo C, Fabbri A.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A36. doi: 10.1186/2197-7364-2-S1-A36. No abstract available.

29.

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.

Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.

Oncotarget. 2015 Mar 10;6(7):4920-35.

30.

A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma.

Galasso M, Dama P, Previati M, Sandhu S, Palatini J, Coppola V, Warner S, Sana ME, Zanella R, Abujarour R, Desponts C, Teitell MA, Garzon R, Calin G, Croce CM, Volinia S.

Genome Med. 2014 Oct 2;6(10):76. doi: 10.1186/s13073-014-0076-4. eCollection 2014.

31.

Pluripotent stem cell miRNAs and metastasis in invasive breast cancer.

Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, Sana ME, Di Leva G, Gasparini P, Dama P, Marchesini J, Galasso M, Manfrini M, Zerbinati C, Corrà F, Wise T, Wojcik SE, Previati M, Pichiorri F, Zanesi N, Alder H, Palatini J, Huebner KF, Shapiro CL, Negrini M, Vecchione A, Rosenberg AL, Croce CM, Garzon R.

J Natl Cancer Inst. 2014 Oct 11;106(12). pii: dju324. doi: 10.1093/jnci/dju324. Print 2014 Dec. Erratum in: J Natl Cancer Inst. 2014 Nov:106(11):dju373doi:10.1093/jnci/dju373. Garzon, Maria Elena Sana Ramiro [Corrected to Garzon, Ramiro and Sana, Maria Elena].

32.

A miRNA signature for defining aggressive phenotype and prognosis in gliomas.

Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P, Copetti M, Valori VM, Maiello E, Carella M, Fazio VM, Parrella P.

PLoS One. 2014 Oct 3;9(10):e108950. doi: 10.1371/journal.pone.0108950. eCollection 2014.

33.

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis.

Fassan M, Dall'Olmo L, Galasso M, Braconi C, Pizzi M, Realdon S, Volinia S, Valeri N, Gasparini P, Baffa R, Souza RF, Vicentini C, D'Angelo E, Bornschein J, Nuovo GJ, Zaninotto G, Croce CM, Rugge M.

Oncotarget. 2014 Aug 30;5(16):7162-71.

34.

A simple method to equalize the workload when operating several small wastewater treatment plants: a case study.

De Feo G, De Gisi S, Galasso M.

Environ Technol. 2013 May-Jun;34(9-12):1533-41.

PMID:
24191488
35.

A comparison of the efficacy of organic and mixed-organic polymers with polyaluminium chloride in chemically assisted primary sedimentation (CAPS).

De Feo G, Galasso M, Landi R, Donnarumma A, De Gisi S.

Environ Technol. 2013 May-Jun;34(9-12):1297-305.

PMID:
24191462
36.

Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects.

Guaran V, Astolfi L, Castiglione A, Simoni E, Olivetto E, Galasso M, Trevisi P, Busi M, Volinia S, Martini A.

Int J Mol Med. 2013 Oct;32(4):785-94. doi: 10.3892/ijmm.2013.1470. Epub 2013 Aug 16.

37.

Next generation analysis of breast cancer genomes for precision medicine.

Previati M, Manfrini M, Galasso M, Zerbinati C, Palatini J, Gasparini P, Volinia S.

Cancer Lett. 2013 Oct 1;339(1):1-7. doi: 10.1016/j.canlet.2013.07.018. Epub 2013 Jul 20. Review.

PMID:
23879964
38.

Full-scale treatment of wastewater from a biodiesel fuel production plant with alkali-catalyzed transesterification.

De Gisi S, Galasso M, De Feo G.

Environ Technol. 2013 Mar-Apr;34(5-8):861-70.

PMID:
23837337
39.

Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.

Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Santhanam R, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CM.

PLoS Genet. 2013;9(3):e1003311. doi: 10.1371/journal.pgen.1003311. Epub 2013 Mar 7. Erratum in: PLoS Genet. 2013 Apr;9(4). doi:10.1371/annotation/92dfa670-d431-4d68-b70b-706df1f93e46. Ramasamy, Santhanam [corrected to Santhanam, Ramasamy].

40.

miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.

Sandhu SK, Volinia S, Costinean S, Galasso M, Neinast R, Santhanam R, Parthun MR, Perrotti D, Marcucci G, Garzon R, Croce CM.

Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20047-52. doi: 10.1073/pnas.1213764109. Epub 2012 Nov 19.

41.

Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer.

Ciancio N, Galasso MG, Campisi R, Bivona L, Migliore M, Di Maria GU.

Multidiscip Respir Med. 2012 Sep 14;7(1):29. doi: 10.1186/2049-6958-7-29.

42.

MicroRNA expression signatures in solid malignancies.

Galasso M, Sandhu SK, Volinia S.

Cancer J. 2012 May-Jun;18(3):238-43. doi: 10.1097/PPO.0b013e318258b5f4. Review.

PMID:
22647360
43.

miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI.

Cancer Res. 2012 Apr 1;72(7):1865-77. doi: 10.1158/0008-5472.CAN-11-2663. Epub 2012 Feb 20.

44.

Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.

Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3024-9. doi: 10.1073/pnas.1200010109. Epub 2012 Feb 6.

45.

Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma.

Sollazzo V, Galasso M, Volinia S, Carinci F.

J Orthop Res. 2012 Jun;30(6):1004-12. doi: 10.1002/jor.22034. Epub 2011 Dec 6.

46.

GAMES identifies and annotates mutations in next-generation sequencing projects.

Sana ME, Iascone M, Marchetti D, Palatini J, Galasso M, Volinia S.

Bioinformatics. 2011 Jan 1;27(1):9-13. doi: 10.1093/bioinformatics/btq603. Epub 2010 Oct 22.

PMID:
20971986
47.

Reprogramming of miRNA networks in cancer and leukemia.

Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM.

Genome Res. 2010 May;20(5):589-99. doi: 10.1101/gr.098046.109.

48.

Non-coding RNAs: a key to future personalized molecular therapy?

Galasso M, Sana ME, Volinia S.

Genome Med. 2010 Feb 18;2(2):12. doi: 10.1186/gm133.

49.

Identification of microRNA activity by Targets' Reverse EXpression.

Volinia S, Visone R, Galasso M, Rossi E, Croce CM.

Bioinformatics. 2010 Jan 1;26(1):91-7. doi: 10.1093/bioinformatics/btp598. Epub 2009 Nov 6.

50.

Groundwater recharge in an endoreic basin with reclaimed municipal wastewater.

De Feo G, Galasso M, Belgiorno V.

Water Sci Technol. 2007;55(1-2):449-57.

PMID:
17305170

Supplemental Content

Loading ...
Support Center